Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dane Cheasley

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Stem Cells (Dayton, Ohio)|October 15, 2011
Myb controls intestinal stem cell genes and self-renewalDane Cheasley, Lloyd Pereira, Sally Lightowler, et al.
Stem Cell Research|October 8, 2014
Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesisMarkus Germann, Huiling Xu, Jordane Malaterre, et al.
Histopathology|November 5, 2020
Primary mucinous ovarian neoplasms rarely show germ cell histogenesisFelix K F Kommoss, Dane Cheasley, Matthew J Wakefield, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 24, 2024
Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous CarcinomaAnnalyn Da-Anoy, Eun Young Kang, Cheng Han Lee, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
The Journal of Pathology|February 13, 2018
Molecular analysis of PALB2-associated breast cancersJue Er Amanda Lee, Na Li, Simone M Rowley, et al.
Cancer Research|September 28, 2011
MYB is essential for mammary tumorigenesisRebecca Yu Miao, Yvette Drabsch, Ryan Stanley Cross, et al.
NPJ Breast Cancer|January 8, 2026
Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profilesDane Cheasley, Meagan Ruppert, Lisa Devereux, et al.
NPJ Genomic Medicine|January 10, 2025
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencingDeepak N Subramanian, Maia Zethoven, Kathleen I Pishas, et al.
Scientific Data|September 19, 2024
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian CarcinomaKathleen I Pishas, Karla J Cowley, Marta Llaurado-Fernandez, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Stem Cells (Dayton, Ohio)|October 15, 2011
Myb controls intestinal stem cell genes and self-renewalDane Cheasley, Lloyd Pereira, Sally Lightowler, et al.
Stem Cell Research|October 8, 2014
Tripartite interactions between Wnt signaling, Notch and Myb for stem/progenitor cell functions during intestinal tumorigenesisMarkus Germann, Huiling Xu, Jordane Malaterre, et al.
Histopathology|November 5, 2020
Primary mucinous ovarian neoplasms rarely show germ cell histogenesisFelix K F Kommoss, Dane Cheasley, Matthew J Wakefield, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 24, 2024
Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous CarcinomaAnnalyn Da-Anoy, Eun Young Kang, Cheng Han Lee, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
The Journal of Pathology|February 13, 2018
Molecular analysis of PALB2-associated breast cancersJue Er Amanda Lee, Na Li, Simone M Rowley, et al.
Cancer Research|September 28, 2011
MYB is essential for mammary tumorigenesisRebecca Yu Miao, Yvette Drabsch, Ryan Stanley Cross, et al.
NPJ Breast Cancer|January 8, 2026
Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profilesDane Cheasley, Meagan Ruppert, Lisa Devereux, et al.
NPJ Genomic Medicine|January 10, 2025
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencingDeepak N Subramanian, Maia Zethoven, Kathleen I Pishas, et al.
Scientific Data|September 19, 2024
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian CarcinomaKathleen I Pishas, Karla J Cowley, Marta Llaurado-Fernandez, et al.
Pageof 3